Literature DB >> 20155623

Molecular mechanisms of green tea polyphenols.

Q Ping Dou1.   

Abstract

Tea, next to water, is the most popular beverage in the world. It has been suggested that tea consumption has the cancer-preventive effects. Epidemiological studies have indicated decreased cancer occurrence in people who regularly drink green tea. Research has also discovered numerous mechanisms of action to explain the biological effects of tea. The most abundant and popular compound studied in tea research is (-)-epigallocatechin-3-gallate or (-)-EGCG, which is a powerful antioxidant and can inhibit a number of tumor cell proliferation and survival pathways. Tea polyphenols are known to inhibit metaloproteonases, various protein kinases, and proteins that regulate DNA replication and transformation. We also reported that ester bond-containing tea polyphenols, for example, (-)-EGCG, potently and specifically inhibited the tumor proteasomal activity. We further demonstrated that methylation on green tea polyphenols under physiological conditions decreased their proteasome-inhibitory activity, contributing to decreased cancer-preventive effects of tea consumption. Since (-)-EGCG is unstable under physiological conditions, we also developed the peracetate-protected or prodrug form of (-)-EGCG, Pro-EGCG (1), and showed that Pro-EGCG (1) increases the bioavailability, stability, and proteasome-inhibitory and anticancer activities of (-)-EGCG in human breast cancer cells and tumors, demonstrating its potential use for cancer prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20155623      PMCID: PMC3769684          DOI: 10.1080/01635580903285049

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  103 in total

Review 1.  Ubiquitin-mediated proteolysis: biological regulation via destruction.

Authors:  A Ciechanover; A Orian; A L Schwartz
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

2.  Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells.

Authors:  S Islam; N Islam; T Kermode; B Johnstone; H Mukhtar; R W Moskowitz; V M Goldberg; C J Malemud; T M Haqqi
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

3.  Growth factor-dependent induction of p21(CIP1) by the green tea polyphenol, epigallocatechin gallate.

Authors:  M Liberto; D Cobrinik
Journal:  Cancer Lett       Date:  2000-06-30       Impact factor: 8.679

4.  Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.

Authors:  F Larcher; A I Robles; H Duran; R Murillas; M Quintanilla; A Cano; C J Conti; J L Jorcano
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

5.  Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells.

Authors:  S J Berger; S Gupta; C A Belfi; D M Gosky; H Mukhtar
Journal:  Biochem Biophys Res Commun       Date:  2001-10-19       Impact factor: 3.575

6.  Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells.

Authors:  Deborah Kuhn; Wai Har Lam; Aslamuzzaman Kazi; Kenyon G Daniel; Shuojing Song; Larry M C Chow; Tak Hang Chan; Q Ping Dou
Journal:  Front Biosci       Date:  2005-05-01

7.  Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression.

Authors:  B Li; Q P Dou
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

8.  Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells.

Authors:  Y D Jung; K Nakano; W Liu; G E Gallick; L M Ellis
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

Review 9.  Antimutagenic and anticarcinogenic activity of tea polyphenols.

Authors:  Y Kuroda; Y Hara
Journal:  Mutat Res       Date:  1999-01       Impact factor: 2.433

10.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  17 in total

1.  Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols.

Authors:  Stephen J Glynn; Kevin J Gaffney; Marcos A Sainz; Stan G Louie; Nicos A Petasis
Journal:  Org Biomol Chem       Date:  2015-04-07       Impact factor: 3.876

2.  Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects.

Authors:  Mohammad A Shahshahan; Maureen N Beckley; Ali R Jazirehi
Journal:  Am J Cancer Res       Date:  2011-08-23       Impact factor: 6.166

3.  A preliminary investigation of the impact of catechol-O-methyltransferase genotype on the absorption and metabolism of green tea catechins.

Authors:  Rosalind J Miller; Kim G Jackson; Tony Dadd; Beate Nicol; Joanne L Dick; Andrew E Mayes; A Louise Brown; Anne M Minihane
Journal:  Eur J Nutr       Date:  2011-03-29       Impact factor: 5.614

4.  Stability of Polyphenols Epigallocatechin Gallate and Pentagalloyl Glucose in a Simulated Digestive System.

Authors:  Melanie A Krook; Ann E Hagerman
Journal:  Food Res Int       Date:  2012-08-04       Impact factor: 6.475

5.  Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.

Authors:  Piwen Wang; Jaydutt V Vadgama; Jonathan W Said; Clara E Magyar; Ngan Doan; David Heber; Susanne M Henning
Journal:  J Nutr Biochem       Date:  2013-10-10       Impact factor: 6.048

6.  Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.

Authors:  Tsogzolmaa Dorjgochoo; Yu-Tang Gao; Wong-Ho Chow; Xiao-ou Shu; Gong Yang; Qiuyin Cai; Nathaniel Rothman; Hui Cai; Honglan Li; Xinqing Deng; Adrian Franke; L Jackson Roberts; Ginger Milne; Wei Zheng; Qi Dai
Journal:  Am J Clin Nutr       Date:  2012-07-03       Impact factor: 7.045

Review 7.  EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.

Authors:  Di Chen; Sheng Biao Wan; Huanjie Yang; Jian Yuan; Tak Hang Chan; Q Ping Dou
Journal:  Adv Clin Chem       Date:  2011       Impact factor: 5.394

Review 8.  Therapeutic properties of green tea against environmental insults.

Authors:  Lixia Chen; Huanbiao Mo; Ling Zhao; Weimin Gao; Shu Wang; Meghan M Cromie; Chuanwen Lu; Jia-Sheng Wang; Chwan-Li Shen
Journal:  J Nutr Biochem       Date:  2016-05-27       Impact factor: 6.048

Review 9.  New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.

Authors:  Shahnjayla K Connors; Ganna Chornokur; Nagi B Kumar
Journal:  Nutr Cancer       Date:  2011-11-18       Impact factor: 2.900

10.  Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate.

Authors:  Joshua D Lambert; Shengmin Sang; Jungil Hong; Chung S Yang
Journal:  J Agric Food Chem       Date:  2010-09-22       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.